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Abstract
Background: Febrile seizures are the most common form of childhood seizures. Among pro-inflammatory
cytokines, interleukin-6 is the key acute-phase cytokine. To date, only a few studies concerned the association of
interleukin-6 gene polymorphisms with febrile seizures.In this study, we aimed to investigate 3 cytokine single-
nucleotide polymorphisms situated at positions –174 (G/C), –572 (G/C), and –597 (G/A) in the promoter region of
the interleukin-6 gene for the first time in Egyptian children with febrile seizures.
Methods: This was a case–control study included 100 patients with febrile seizure, and matched with age, gender,
ethnicity 100 healthy control subjects.
Interleukin-6 –174 (G/C), −572 (G/C), and −597 (G/A) polymorphisms were genotyped by polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP), while the serum IL6 levels were measured by ELISA
method.
Results: Compared to the controls subjects, the frequency of the −174 GG and −597 GG IL6 genotypes were
observed to be increased in children with febrile seizures (OR: 4.17; 95 % CI: 1.86–9.49; P <0.01 and OR: 1.96; 95 %
CI: 1.06–3.63;P <0.05, respectively). We found a significant positive association between the −597 GG genotype and
susceptibility to complex febrile seizures as did the G allele at the same position (OR: 4.2; 95 % CI: 1.4–13.3 for the
GG genotype; P <0.01) and (OR: 2.89; 95 % CI: 1.1–7.7 for the G allele; P <0.05 respectively). Our data revealed no
association between IL6- genotypes and serum IL6 levels in patients with febrile seizures (P > 0.05).
Conclusion: In conclusion, our data brought a novel observation that the presence of a G allele or GG genotype at
the −174 and the GG genotype at the −597 positions of the promoter region of the interleukin-6 gene constitute
risk factors for developing febrile seizures in Egyptian children. Moreover, we observed a significant positive
association between the IL6 –597 GG genotype and susceptibility to complex febrile seizures as did the G allele at
the same position. However, we found no association between IL6- genotypes and serum IL6 levels in patients with
febrile seizures.
Keywords: Febrile seizure, Gene polymorphisms, Cytokines, Interleukin-6
* Correspondence: Seham_Azab@yahoo.com
1Faculty of Medicine, Zagazig University, 18 Omar Bin Elkhattab St, Al
Qawmia, Zagazig City, AlSharqia Governorate, Egypt
Full list of author information is available at the end of the article
© 2016 Azab et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Azab et al. Italian Journal of Pediatrics  (2016) 42:31 
DOI 10.1186/s13052-016-0244-9
Background
Febrile seizures are the most common form of childhood
seizures. It has been reported that one in every 25
children in the population will experience at least one
febrile seizure during their childhood [1]. Febrile
seizures are defined by the International League Against
Epilepsy as “elevated or rapidly rising fever of short dur-
ation associated with uncomplicated seizure that does
not predispose to epilepsy and is not accompanied by
any neurologic abnormality, no previous neonatal
seizures or a previous unprovoked seizure, and not
meeting the criteria for other acute symptomatic sei-
zures in children between 6 months and 5 years of age
[2]. Febrile seizures were classified into three types: sim-
ple, complex, and febrile status epilepticus [3]. While
cohort studies reported that prognosis of febrile seizures
is good, epilepsy is observed in 5.4 % of these patients
[4]. The main modulator of the condition is the seizure
threshold, which varies strongly between individuals and
is influenced by age, maturation, and genetic predispos-
ition [5].
During infection, pro-inflammatory cytokines such as
interleukin 1B (IL-1B), interleukin 6 (IL-6) and tumor
necrosis factor-a (TNF-a) participate in inducing acute-
phase reaction including fever [6]. Cytokines also play
an important role in the protection of neurons against
ischemia and cytotoxic damage in prolonged febrile sei-
zures [6]. A dual role of IL-6 in seizures has been dem-
onstrated in experimental models. An earlier study by
Biber et al. [7] confirmed that stimulation of astrocytes
and brain slices of cortex with IL-6 induced adenosine
A1 receptor mRNA which is a powerful endogenous
anti-convulsive substance. Fakuda et al. [8] reported that
interleukin-6 plays an anti-convulsive role in experimen-
tal hyperthermia-induced seizures which might suggest
similar properties of this cytokine in children with febrile
seizures. On the other hand, intranasal administration of
IL-6 exacerbated the severity of seizures induced by pen-
tylenetetrazole on models of FS, supporting a pro-
convulsant effect [9].
Complex interaction between immune-inflammatory
process, cytokines activation, and genetic factors is
involved in febrile seizures pathogenesis [10]. Recent
studies suggested that cytokine genes single nucleotide
polymorphisms is, at least in part, an aetiopathogenetic
factor in the manifestation of febrile seizures, particu-
larly in sporadic cases [11–14]. To date, only a few stud-
ies concerned the association of interleukin-6 gene
polymorphisms with febrile seizures and the susceptibil-
ity to febrile seizures.
On the basis of these considerations, we designed this
study to investigate 3 cytokine single-nucleotide poly-
morphisms situated at positions −174 (G/C), –572
(G/C), and –597 (G/A) in the promoter region of the
interleukin-6 gene for the first time in Egyptian children
with febrile seizures.
Methods
This was a prospective case–control study performed in
Zagazig University Children Hospital, and outpatient
clinics in the same hospital from October 2013 to
August 2015.
One hundred children; who had febrile seizures as
diagnosed in the Department of Pediatrics in the same
hospital, were enrolled in this study. The age of the
patients ranged from 6 months to 6 years (median,
38 months). Diagnosis of febrile seizures followed the
criteria established in the 1989 International Classifica-
tion of Epileptic Syndromes [15]. Febrile seizures were
defined as events in infancy or childhood that usually
occur between 6 months and 5 years of age and are
associated with a fever, but without evidence of intracra-
nial infection or a defined cause for the seizure. Simple
febrile seizures are generalized in onset, last less than
15 min, and do not occur more than once in 24 h. Com-
plex seizures last longer, have focal symptoms, and can
recur within 24 h. The electroencephalogram (EEG) was
normal for all patients or showed mild nonspecific
abnormalities.
Exclusion criteria
Patients with febrile seizures beginning at the age of
6 years or later, afebrile seizures, evidence of intracranial
infection or epileptiform EEG traits.
One hundred healthy children, of comparable age and
gender; who attended Pediatric Department for
preoperative evaluation for elective surgery, without a
history of febrile seizures were enrolled. Patients and
controls belonged to the same ethnic group: African
Caucasian. All patients and controls included were sub-
jected to proper history taking, thorough clinical and de-
tailed neurological examination.
Blood sampling
Blood was obtained from patients within 30 min of the
time of seizure, and divided into 2 portions: 2 ml of
whole blood was collected into tubes containing EDTA,
for genomic DNA extraction. Serum were separated
immediately from remaining part of the samples and
stored at _20 _C till the time of use. Control samples
were collected and similarly analyzed.
Genomic DNA extraction
Genomic DNA was extracted from EDTA whole blood
sample using a spin column method according to the
protocol (QIAamp Blood Kit; Qiagen GmbH, Hilden,
Germany). DNA was stored at 20 _C until analysis.
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IL6- Genotyping
All subjects were genotyped for IL6- polymorphism by
polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP) as described before [13].
However, the results in some cases were not promising;
and the experts did not accept it; therefore, few cases
were excluded.
Measurement of serum interleukin 6 (IL6) levels
The concentrations of IL6 in serum were estimated
using a double antibody sandwich ELISA (kit provided
by Biosource EuropeS.A., Belgium) according to the
manufacturer’s instructions by using standard curve.
Statistical analysis
IL6 genotype and allele frequencies in patients and con-
trols were tested for Hardy–Weinberg equilibrium and
any deviation between the observed and expected fre-
quencies was tested for significance using chi-square
and Fisher exact tests. In addition, the odds ratios (ORs)
and 95 % confidence intervals (CIs) were calculated as a
measure of the association between interleukin-6 (−174,
−572, and −597) SNP and febrile seizures. The Student t
test and analysis of variance were used to compare nu-
meric variables within groups, depending on the distri-
bution of the data. P value < 0.05 was considered to be
statistically significant. All data were analyzed using the
Epi Info statistical software (version 6.2, World Health
Organization, Geneva, Switzerland).
Ethics
Informed parental consent was obtained to be eligible
for enrollment into the study. The study was done ac-
cording to the rules of the Local Ethics Committee of
Faculty of Medicine, Zagazig University, Egypt. Our in-
stitutional review committee of ethical research ap-
proved the study.
Results
Our study included 100 patients with FS (63 patients
with Simple FS and 37 patients with Complex FS, their
age ranged from 6 to 72 months (median 38 months), 51
males and 49 females) and 100 healthy control subjects
whose characteristics are listed in Table 1. The control
group were age and gender matched to children with FS.
The mean age at the onset of febrile seizures was
18 months (range, 6–43months). Within the group with
complex febrile seizures, 23 patients had experienced
two or more seizures, five patients had experienced focal
seizures, and nine patients had experienced prolonged
seizures lasting longer than 20 min. Thirty-one patients
had a family history of febrile seizures, and 15 patients
had a family history of epilepsy. As expected, patients
with FS had increased serum levels of IL6 compared to
the control group (mean, 32.7 pg/ml versus 10.5 pg/ml;
P < 0.01, respectively); (Table 1).
Compared to the controls subjects, the frequency of
the −174 GG and −597 GG IL6 genotypes were observed
to be increased in children with febrile seizures (OR:
4.17; 95 % CI: 1.86–9.49; P <0.01 and OR: 1.96; 95 % CI:
1.06–3.63;P <0.05, respectively); Table 2.
No significant association was evident between IL6
genotype and a positive family history of febrile seizures
or epilepsy among studied patients; (P <0.05).
We found a significant increase in the frequency of
the G allele (OR: 1.84; 95 % CI: 1.21–2.8; P <0.01) at the
−174 position in IL-6 among the febrile seizure patients;
where a concomitant significant decrease in the fre-
quency of the C allele at the same position was observed
compared to the control group (OR: 0.54; 95 % CI:
0.36–0.82; P <0.01); Table 3. On the other hand, no sig-
nificant differences were found between the 2 groups in
the allele frequencies for the −572 and −597 positions;
Table 3.
Of note, when patients with simple or complex febrile
seizures were evaluated, there was a significant positive
association between the −597 GG genotype and suscep-
tibility to complex febrile seizures as did the G allele at
the same position (OR: 4.2; 95 % CI: 1.4–13.3 for the
GG genotype; P <0.01) and (OR: 2.89; 95 % CI: 1.1–7.7
for the G allele; P <0.05 respectively); Table 4. Mean-
while, no significant differences were observed between
the 2 groups genotype or allele frequencies for the–174
and −572 positions; Table 4. However, we could not find
any significant association between IL-6 genotype or al-
lele frequencies and prolonged seizure duration among
subgroups of complex seizure patients (P > 0.05).
Table 1 Baseline clinical and laboratory data of the studied
patients and control groups
Patients Controls P
n = 100 n = 100
Age, months 38(6–72) 35(6–70) >0.05a
Gender (M/F) 51/49 53/47 >0.05b
Type of Febrile seizure :
Simple 63 - -
Complex 37 - -
Age at onset of Febrile seizure (months) 18(6–43) - -
Family history :
Febrile convulsions 31 - -
Epilepsy 15 - -
Serum IL6 pg/ml 32.7 ± 5.9 10.5 ± 1.7 <0.01c
Abbreviations: IL6 interleukin 6
Data are presented as median (Range) or mean ± SD
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Patients with simple febrile seizures had serum IL6
levels similar to those with complex febrile seizures
(P > 0.05); Table 4.
Our data revealed no significant association between
IL6- genotypes or alleles and serum IL6 levels in patients
with febrile seizures (P > 0.05); Table 5.
Discussion
Pro-inflammatory cytokines as a key factor of host re-
sponse to infection induct fever, leukocytosis, and acute
phase protein synthesis [6]. Among these cytokines,
interleukin-6 is a cell signaling molecule that has been
associated with many diseases, including inflammatory,
Table 2 Distribution of IL-6 genotypes in patients with febrile seizures (FS) and the control group
Gene Polymorphism Genotype Patients n(%) Controls n(%) OR(95 % CI) P
IL-6 (−174) Sample size 100 100
GG 34 (34) 11(11) 4.17(1.86–9.49) <0.01
GC 57(57) 73(73)
CC 9(9) 16 (16)
IL-6 (−572) Sample size 98 100
GG 69(70.4) 65(65) >0.05
GC 25(25.5) 33(33)
CC 4(4.1) 2(2)
IL-6 (−597) Sample size 95 100
GG 62(65.3) 49(49) 1.96(1.06–3.63) <0.05
GA 31(32.6) 48(48)
AA 2(2.1) 3(3)
Serum IL6 pg/ml 32.7 ± 5.9 10.5 ± 1.7 <0.01a
Abbreviations: IL6 interleukin 6, FS febrile seizures, OR odds ratio, CI 95 % confidence interval
Values in parentheses are percentages or data are presented as mean ± SD
P value < 0.05 indicates a significant difference
Chi-square test
a (Student t-test)
Table 3 Distribution of IL-6 Alleles Frequency in patients with







OR(95 % CI) P
IL-6 (−174) Sample size 100 100
G 125(63) 95(48) 1.84 (1.21–2.8) <0.01
C 75(37) 105(52) 0.54(0.36–0.82) <0.01
IL-6 (−572) Sample size 98 100
G 163(83) 163(81) >0.05
C 33(17) 37(19)
IL-6 (−597) Sample size 95 100
G 155(82) 146(73) >0.05
A 35(18) 54(27)
Abbreviations: IL6 interleukin 6, FS febrile seizures, OR odds ratio, CI 95 %
confidence interval
P value < 0.05 indicates a significant difference
Chi-square test
Table 4 Comparison of Genotype and Allele Frequency of IL-6
Polymorphisms between patients with simple febrile Seizure
(SFS) and those with complex febrile seizures (CFS)





IL-6 (−174) Sample size 63 37
GG 6(10) 3(8) >0.05
GC 36(57) 21(57)
CC 21(33) 13(35)
Alleles G 48(38) 27(36) >0.05
C 78(62) 47(64)
IL-6 (−572) Sample size 61 37
GG 44(72) 25(68) >0.05
GC 15(25) 10(27)
CC 2(3) 2(5)
Alleles G 103(84) 60(81) >0.05
C 19(16) 14(19)
IL-6 (−597) Sample size 59 36
GG 32(54) 30(83) <0.01
GA 26(44) 5(14)
AA 1(2) 1(3)
Alleles G 90(76) 65(90) <0.05
A 28(24) 7(10)
Serum IL6 pg/ml 31.5 ± 6.9 33.7 ± 5.6 >0.05a
Abbreviations: IL6 interleukin 6, SFS Simple febrile seizures, CFS Complex
febrile seizures
P value < 0.05 indicates a significant difference. Chi-square test. aStudent t-test
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neurological, vascular, and malignant processes [16, 17].
Because of potential immune-modulatory effects of IL-6
and its importance as a major pro-inflammatory cyto-
kine, IL-6 gene polymorphisms might affect individual
susceptibility to febrile seizures.
In the present study, we found a significant positive
associations between febrile seizure and the interleukin-
6 G allele at the −174 position (OR: 1.84; P <0.01) and
the −174 GG or −597 GG genotypes (OR: 4.17, and 1.96;
P <0.01; respectively), thus revealing that patients were
more susceptible to febrile seizure. Furthermore, we
detected a significant negative association between fe-
brile seizure and the C allele at the −174 position (OR:
0.54; P <0.01) indicating that this association could rep-
resent a protective effect against febrile seizures. These
results were concordant with those of Nur et al. [13]
who reported that the presence of the G allele or the
GG genotype at −174 and the GG genotype at −572 po-
sitions of the interleukin-6 promoter regions constituted
risk factors for developing febrile seizures in Turkish
children. These findings support the hypothesis that a
positive genotype predisposes individual to febrile seiz-
ure. However, we did not find a significant association
between febrile seizure and the genotype or allele
frequencies for the −572 position of the IL-6 promoter
regions as they did.
On the contrary, Shahrokhi et al. [14] studied IL6 gene
(−174 and +565) SNPs on genomic DNAs of 90 Iranian
children with febrile seizures, compared to 139 healthy
subjects. They reported that the presence of the G allele
or the GG genotype at +565 position reduced risk of FS,
while the A allele at +565 position of the promoter re-
gions was a constituted risk factor for developing FS.
However, the previous study on Taiwanese population
by Chou et al. [18] failed to detect any association be-
tween interleukin-6 promoter gene polymorphism and
febrile seizures. The authors also stated that no signifi-
cant difference was observed in the distribution of allele
frequencies of the IL-6 promoter, IL-1b promoter, IL-1b
exon 5, IL-8, IL-10, or the tumor necrosis factor (TNF
− α), gene polymorphisms.
Discrepancies between previously published studies
and our study might be explained by the differences in
age; study design or geographic/ethnicity, or by gene-
gene or gene-environmental interactions. The genetic
predisposition to febrile seizures could be polygenic,
with many variants in multiple gene loci, playing an im-
portant role.
Of note, our data confirms a significant positive asso-
ciation between the IL6 –597 GG genotype and suscep-
tibility to complex febrile seizures as did the G allele at
the same position (OR: 4.2 and 2.89, respectively). How-
ever, no significant relationship was evident between IL-
6 genotype or allele frequencies and prolonged seizure
duration among subgroups of complex seizure patients.
Similar to our results, Nur et al. [13] found a signifi-
cantly higher frequency of the GG homozygous variant
at position −597 of the IL6 gene in complex cases com-
pared to patients with simple febrile seizures.
A positive family history of febrile seizure is the
most meaningful risk factor, and the more relatives
affected, the greater the risk is [19]. On the basis of
family studies, the febrile seizure susceptibility trait is
inherited in an autosomal dominant manner with re-
duced penetrance in large families. Linkage analysis
revealed seven putative febrile seizure loci, chromo-
somes 8q, 19p, 2q, 5q, 6q, 18p, and 3p, which are at
least partly associated with epilepsy or afebrile sei-
zures [20]. By contrast, the inheritance appears to be
polygenic or multifactorial in small families or spor-
adic cases. Surprisingly, we did not observe any sig-
nificant association of IL6 gene polymorphism with a
positive family history of febrile seizures among the
studied patients (P > 0.05), which was contrary to our
expectations and to previous findings of recent
reports [13, 14] that the GG genotype at −174 was
observed to be higher in familial cases which com-
prised a risk factor for febrile seizures.
Table 5 Association of IL6 genotypes and alleles with serum IL-
6 levels in febrile seizures patients
Gene Polymorphism Genotype/Alleles Serum IL6 (pg/ml) P
IL-6 (−174) GG 37.5 ± 6.9 >0.05a
GC 35.3 ± 4.5
CC 33.5 ± 5.7
Alleles
G 36.7 ± 3.8 >0.05b
C 35.5 ± 6.4
IL-6 (−572) GG 33.7 ± 4.5 >0.05a
GC 35.5 ± 5.7
CC 38.4 ± 3.9
Alleles
G 34.2 ± 5.3 >0.05b
C 39.5 ± 4.6
IL-6 (−597) GG 45.5 ± 9.7 >0.05a
GA 43.3 ± 5.5
AA 47.5 ± 7.9
Alleles
G 44.5 ± 5.3 >0.05 b
A 49.7 ± 8.5
Abbreviations: IL6 interleukin 6
Data are presented as mean ± SD
P value < 0.05 indicates a significant difference
aCalculated by ANOVA test
bStudent t-test
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It may be assumed that environmental factors such as
exposure to recurrent viral infections; especially in our
developing countries and host defense response related
to cytokine gene polymorphism may be the cause of
sporadic cases of febrile seizures and can play a signifi-
cant role in their manifestation. Certainly, the small
number of studies concerning cytokine gene polymor-
phisms, particularly in Caucasian population, makes it
difficult to express explicitly the hypotheses or concepts.
IL6 is a pleiotropic cytokine secreted by a variety of
cells such as T-lymphocytes, macrophages, endothelial
cells and epithelial cells. The systemic concentration of
IL6 is mainly regulated at the level of expression, as IL6
is rapidly cleared from the plasma with a short plasma
half-life of 20–60 min [21].
As expected, we found that mean systemic IL6 levels
in patients with febrile seizure was markedly elevated
compared to the control group. However, patients with
complex febrile seizure had serum IL6 levels similar to
those with simple febrile seizure. Many other studies
[22–24] reported the same findings, together with our
results, may support the pro-convulsant action of IL-6
in febrile seizures. Virta et al. [22] found that the plasma
interleukin-6 levels and interleukin-1 receptor antagonist
were significantly higher in patients with febrile seizures,
compared with febrile control subjects and CSF IL-6
levels were detectable in all studied patients with FS.
Lehtimäki et al. [23] explained that increased serum
levels of cytokines originate mainly from the endothe-
lial cells of the brain vessels and partially from the
CSF compartment. The authors added that increased
brain pro-inflammatory cytokines decrease the thresh-
old for individual seizures; supporting the suggestion
that neuro-inflammation may contribute to epilepto-
genesis in the developing brain [22–24]. On the other
hand, Güven et al. [25] studied serum interleukin 6
levels, adiponectin and leptin as adipocytokines in
children with febrile seizures compared with febrile
control children. This research concluded that
elevated levels of these adipocytokines as acute phase
reactants in FS and FC groups did not contribute to
the development of FS.
Interestingly, we observed that there was a lack of as-
sociation between IL6- genotypes or alleles and serum
IL6 levels in our patients with febrile seizures (P > 0.05).
Against our results, Terry et al. [26] reported that the
IL6-174G/C polymorphism affects transcription by alter-
ing the serum level of IL6, with the C allele associated
with lower plasma IL6 concentrations. Endler et al. [27]
added that other promoter polymorphisms within the
IL6 gene, such as the IL6-572G/C polymorphism or
complex haplotypes of other polymorphisms had been
discussed as influencing IL6 plasma levels during the
period of febrile disease.
However, more studies on cytokine profiles in the
serum of child patients with febrile seizures or epilepsy
are needed for a definite conclusion.
To the best of our knowledge, we demonstrated for
the first time the association between certain genotype,
and allele frequencies in IL-6 gene with febrile seizure in
the Egyptian population. However, the small sample size
was one of our limitations in this study; we suggest that
multicenter approaches may be necessary to attain larger
sample size. CSF IL-6 and interictal cytokine levels were
not measured in our patients with febrile seizures which
were other limitations in our study.
Conclusion
In conclusion, our data brought a novel observation that
the presence of a G allele or GG genotype at the −174
and the GG genotype at the −597 positions of the pro-
moter region of the interleukin-6 gene constitute risk
factors for developing febrile seizures in Egyptian
children. Moreover, we observed a significant positive
association between the IL6 –597 GG genotype and sus-
ceptibility to complex febrile seizures as did the G allele
at the same position. However, we found no association
between IL6- genotypes and serum IL6 levels in patients
with febrile seizures.
Finally, further studies and more genetic information
on ethnicities from different parts of the world will pro-
vide an additional understanding of the possible role of
cytokine gene polymorphisms in the susceptibility to
febrile seizure and progression to epilepsy.
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